MCUJF · Medicure Inc
Market Cap
$34.85M
Shares
11.21M
Volume · Oct 21
576
Avg daily vol (3M)
14.3K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.13
Open$3.11
Day$3.11–3.13
52W close$0.67–3.13
Avg vol 30d15K
Short int48K · 0.4% float · 2.0d
Short vol80%
Last earningsAug 17, 2026
DataJan 2020–Oct 2026
Up next
call held Aug 17, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+298.7%
Trailing year
Short interest
0.4%
Latest settlement · 2.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+210%
above
Price vs 50-day avg
+78%
above
RSI (14)
90
overbought
MACD trend
Positive
52-week position
100%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+65%
trailing
6-month return
+526%
trailing
YTD return
+291%
this year
Relative strength
+518%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.43% of float · ▲ +53.9% MoM · 2.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
58
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
134%
annualized · 1-yr
Max drawdown
−65%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+210%
Bullish
Price vs 50-day avg
+78%
Bullish
RSI (14)
90
Bearish
MACD trend
Positive
Bullish
52-week position
100%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $2 › 200d $1 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.43% of float · ▲ +53.9% MoM · 2.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $1
Now $3 · 100%
Range high $3
vs 200-day avg +210%
vs 50-day avg +78%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MCUJF
this stock
Medicure Inc
|
$34.85M | +291.3% | — | — | 0.4% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$64.15B | +27.8% | — | — | 0.1% |
|
GALDY
Galderma Group AG
|
$49.23B | +1.9% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$46.21B | +30.2% | +4.3% | 65.0 | 2.6% |
|
HLN
Haleon plc
|
$44.06B | -0.9% | — | — | 0.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MCUJF | +13.4% | +64.7% | +526.0% | +56.5% | +291.3% |
| SPY | +0.5% | +0.7% | +7.6% | +1.4% | +13.4% |
| vs SPY | +13.0% | +64.1% | +518.4% | +55.1% | +277.9% |